WASATCH ADVISORS LP - Mar 31, 2025 Form SCHEDULE 13G/A Schedule Report for Esperion Therapeutics, Inc. (ESPR)

Filing Manager: WASATCH ADVISORS LP
Reporting Manager: WASATCH ADVISORS LP
Security: Esperion Therapeutics, Inc. Common Stock
Symbol: ESPR
Shares outstanding: 199M shares
Disclosed Ownership: 10.9M shares
Ownership: 5.5%
Form type: SCHEDULE 13G/A
Date filed: 4/7/2025, 02:15 PM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
WASATCH ADVISORS LP	5.5%	10.9M	9.84M	0	Mike Yeates	CEO